Abstract 2534: Underlying mechanism of response to neddylation inhibition in a subset of glioblastoma
Shayesteh R. Ferdosi(Translational Genomics Research Institute), Michael Berens(Translational Genomics Research Institute), Nanyun Tang(Translational Genomics Research Institute), George Reid(European Molecular Biology Laboratory), Ritin Sharma(Translational Genomics Research Institute), Krystine Garcia‐Mansfield(Translational Genomics Research Institute), Patrick Pirrotte(Translational Genomics Research Institute), Harshil Dhruv(Arysta LifeScience (France)), Brett Taylor(Translational Genomics Research Institute), Rita Bybee(Translational Genomics Research Institute), Matthew Lee(Translational Genomics Research Institute), Sen Peng(Translational Genomics Research Institute), Lauren Hartman(Translational Genomics Research Institute), Frank Furnari(University of California San Diego)
Cited by 0
Related Papers
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
|Nature|2017|2k
Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes
|Nature Communications|2019|199
Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers
|Cell Reports|2020|108
Localized Metabolomic Gradients in Patient-Derived Xenograft Models of Glioblastoma
|Cancer Research|2019|99
Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma
|Nature Communications|2018|79